(1 - 10 von 13
)
Antisense Pharma Leads Session on TGF-ß at GEN Drug Discovery Summit...
www.b3cnewswire.com
Then Dr. Piotr Jachimczak, physician and senior scientific advisor at Antisense Pharma, informed about therapies targeting TGF-β. In his doctoral thesis he had already demonstrated for the first time that the targeted inhibition of mRNA encoding TGF-β2 by antisense oligodeoxynucleotides may ...
Join: GEN Drug Discovery Theatre at BIOTECHNICA 2010
www.b3cnewswire.com
Dr. Piotr Jachimczak, physician and senior scientific advisor at Antisense Pharma, Regensburg. Therapies targeting TGF- β – an overview . PD Dr. Peter Hau, section leader
sortiert nach Relevanz / Datum